Mealey's (September 16, 2022, 5:03 PM EDT) -- BOSTON — Drug maker Akorn Operating Co. LLC on Sept. 9 agreed to pay $7.9 million to settle a false claims complaint alleging that the company continued to charge prescription prices for three drugs after the drugs were reclassified to cheaper, over-the-counter status, resulting in false claims being filed with Medicare....